Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Axcel and Accru Partners in connection with the acquisition of Sporrong & Eriksson Revisionsbyrå AB
Mandate

Vinge advises Axcel and Accru Partners in connection with the acquisition of Sporrong & Eriksson Revisionsbyrå AB

February 12, 2025 M&A Employment and Benefits Banking and Finance Commercial Agreements IT, Telecommunications and Outsourcing Intellectual Property Data protection and processing of personal data Real Estate and Construction Financial Regulatory

Vinge has advised Axcel VII and Accru Partners in connection with the acquisition of Sporrong & Eriksson Revisionsbyrå AB.

Sporrong & Eriksson Revisionsbyrå AB is an entrepreneur-led, local business with expertise in accounting, audit, tax, acquisition and advisory services. After the acquisition, Accru Partners consists of 28 independent firms within the aforementioned business areas.

Vinge’s team consisted of Christina Kokko, Egil Svensson, Michella Lina Said and Chris Bastholm (M&A), Narin Melazade and Simon Söderholm (Employment), Sofia Haggren (Banking and Finance), Mario Saad (Commercial Agreements), Elis Allmark (IT), Rebecka Målquist (Intellectual Property), Nicklas Thorgerzon (GDPR), Madelene Andersson (Real Property), Jonna Bondemark (Regulatory), Gulestan Ali and Jonna Fransson (Compliance) and Jessica Öijer (Transaction Support Coordinator).

Related

Vinge advises Sobro on its investment in Västkustens Konstruktionsbyrå

 Västkustens Konstruktionsbyrå has decided to broaden its ownership structure by bringing in Sobro as a new co-partner and majority shareholder. The founders will remain with the company as the CEO and CTO respectively, and as significant shareholders. Västkustens Konstruktionsbyrå is an engineering consultancy company based in Gothenburg with cutting-edge expertise in project management, civil engineering and design.
April 23, 2026

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of SEK 350 million before transaction costs.
April 22, 2026

Vinge has advised Alder on the establishment of Alder Strategic Opportunities Fund I and on a fund credit facility agreement in connection with the fundraising

 Vinge has advised Alder on the establishment of the continuation fund Alder Strategic Opportunities Fund I AB. In connection with the establishment, the fund acquires the portfolio companies SI and SMG from Alder II. Vinge also advised Alder on the entering into of a fund credit facility agreement with SEB.
April 20, 2026